HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics
NRXPNRX Pharmaceuticals(NRXP) Prnewswire·2024-08-26 19:55

30millionTermSheetfromqualifiedlenderfornon−dilutivefinancingforfirstclinicacquisitions;anticipatedclosingwithin60daysExecutedNon−BindingTermSheetwithinitialclinicpartnersgeneratingannualrevenueofover30 million Term Sheet from qualified lender for non-dilutive financing for first clinic acquisitions; anticipated closing within 60 daysExecuted Non-Binding Term Sheet with initial clinic partners generating annual revenue of over 10 million, with additional partners to be selected under this initial funding agreementCompany projects annualized revenues of $100 million through continued acquisition by mid 2025Additional information to be presented at upcoming HC Wainwright Annual Global Investment Confere ...